Efficacy and safety of papillary vs non-papillary access to the calyces in patients undergoing percutaneous lithotripsy: a GRADE-assessed systematic review and meta-analysis.

Int Urol NephrolMay 2, 2026 (epub)
Clinical ResearchUrologyOpen access

Fahad Amin, Ammad Abid, Waleeja Rehaam et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the efficacy and safety of papillary versus non-papillary access in 856 patients undergoing percutaneous nephrolithotomy (PCNL). The analysis found no significant differences in key perioperative outcomes, including hemoglobin drop and transfusion rates, suggesting both techniques are comparably effective.

Key findings

  • No significant difference in hemoglobin drop between papillary and non-papillary access (MD 0.09 g/dL).
  • Transfusion rates were similar for both access methods (OR 1.28).
  • Operative duration did not significantly differ (MD 2.81 min).
  • Stone size was identified as a significant moderator affecting operative duration.

Why it matters

Understanding the comparative outcomes of access techniques in PCNL can guide clinicians in making individualized decisions based on patient-specific factors, potentially improving surgical efficiency and patient safety.

Source

Published in Int Urol Nephrol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Urology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.